Document is current

Any future updates will be listed below

T-DXd plus pertuzumab effective as first-line therapy

Crossref DOI link: https://doi.org/10.1038/s41571-025-01106-x

Published Online: 2025-11-18

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark